GMP Biologics Market, By Product Type (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies), By Application, By Service, By Manufacturing Scale, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4852
|
Published Date
March 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
GMP Biologics Market size was valued at US$ 67,810.87 Million in 2024, expanding at a CAGR of 15.98% from 2025 to 2032.
GMP Biologics are therapeutic products derived from living cells, including monoclonal antibodies, vaccines, recombinant proteins, and advanced cell and gene therapies, that are manufactured in strict compliance with Good Manufacturing Practice (GMP) standards. These standards, enforced by national and international regulatory authorities, ensure that biologics are consistently safe, effective, and of high quality throughout all stages—from raw material sourcing to final packaging. Because of their structural complexity and sensitive production processes, biologics require rigorous oversight and controlled manufacturing environments.
From a global regulatory perspective, organizations such as the World Health Organization (WHO) provide internationally recognized GMP guidelines, which have been adopted by over 100 countries to harmonize pharmaceutical quality standards. Regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have reported a steady increase in approvals of biologics and biosimilars in recent years, highlighting their growing role in treating cancer, autoimmune disorders, and rare diseases. Public health data indicate that biologics now account for a substantial proportion of newly approved therapies in major markets, reflecting strong governmental support for expanding high-quality biomanufacturing capacity and strengthening global pharmaceutical supply chains.
GMP Biologics Market- Market Dynamics
Rising Demand for Advanced Biologic Therapies Driving Long-Term Healthcare Sustainability
Healthcare systems worldwide are increasingly focusing on targeted biologic therapies to manage chronic and complex diseases, given their ability to improve patient outcomes and reduce long-term treatment burdens. This growing emphasis on precision medicine is driving demand for robust GMP-certified manufacturing infrastructure, supporting consistent market growth. As chronic conditions such as cancer and autoimmune disorders contribute substantially to the global disease burden, governments are prioritizing biologics to minimize hospitalizations and lower systemic healthcare costs. For example, India’s Union Budget 2026–27 introduced the “Biopharma SHAKTI” initiative, allocating $1.2 billion to establish a global biologics and biosimilars manufacturing hub. Meanwhile, industry leaders like Pfizer and Eli Lilly are expanding GMP-compliant production capacity to meet rising demand. With the global biologics market projected to surpass $534 billion by 2026, the sector is playing a pivotal role in building a resilient, scalable, and value-driven healthcare ecosystem.
GMP Biologics Market- Segmentation Analysis:
The Global GMP Biologics Market is segmented on the basis of Product Type, Application, Service, Manufacturing Scale, End User, and Region.
Globally, the GMP biologics market is segmented by product type into four main categories: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies. Among these, monoclonal antibodies are expected to remain the most influential segment in the near term. mAbs currently account for the largest share of global biologics revenue due to their proven efficacy in treating chronic and complex conditions such as cancer and autoimmune disorders. Their precision targeting of disease pathways, combined with fewer side effects compared with traditional therapies, has reinforced their clinical importance. The U.S. Food and Drug Administration (FDA) approved a record number of monoclonal antibody therapies in 2024, underscoring their growing role in modern medicine. Leading biopharmaceutical companies, including Roche, AbbVie, and Pfizer, have established extensive mAb portfolios and continue to expand GMP-compliant production capacity to meet global demand, with flagship therapies such as Herceptin (Roche) and Humira (AbbVie) driving sustained market performance.
From a manufacturing perspective, the market is classified into Clinical Scale, Commercial Scale, and Pilot Scale production. Commercial-scale manufacturing is projected to experience significant growth as it enables large-volume, consistent production of approved biologics, ensuring global patient access to therapies including monoclonal antibodies, vaccines, and gene-based treatments. Industry leaders like Samsung Biologics, operating multiple high-capacity GMP plants exceeding hundreds of thousands of liters, are expanding commercial production to fulfill long-term supply agreements with major pharmaceutical partners such as Pfizer. Regulatory bodies, including the FDA, continue to enforce stringent GMP standards for transitioning from clinical or pilot-scale production to full commercial output, highlighting the essential role of commercial-scale infrastructure in delivering reliable, high-quality biologic therapies worldwide.
GMP Biologics Market- Geographical Insights
From a geographical perspective, North America is expected to remain a key hub for GMP biologics manufacturing and innovation, driven by advanced regulatory frameworks and strong public health investment. In the United States, the U.S. Food and Drug Administration (FDA) enforces rigorous GMP compliance, ensuring the consistent production of high-quality biologics, and has approved hundreds of biologic therapies for clinical use. The country hosts one of the world’s largest concentrations of biologics manufacturing facilities and maintains a robust pipeline spanning monoclonal antibodies, vaccines, and recombinant proteins, reflecting both strong domestic demand and advanced industry capabilities. Canada also contributes to the region’s strength, with biologics representing a significant portion of national pharmaceutical spending, highlighting the integration of biotherapeutics into the healthcare system.
From an industry standpoint, leading pharmaceutical and biotechnology companies are actively expanding biologics production capacity in North America to serve domestic and international markets. U.S.-based innovators such as Amgen and Pfizer operate large-scale GMP-compliant facilities and continue to invest in next-generation production technologies. These companies collaborate closely with federal agencies to meet evolving quality standards while improving operational efficiency. In Canada, regulatory frameworks align with international GMP guidelines, facilitating cross-border pharmaceutical activities and investment. Together, regulatory oversight, healthcare demand, and corporate expansion position North America as a pivotal region in the global GMP biologics market.
China GMP Biologics Market- Country Insights
China has emerged as a significant force in biologics manufacturing, driven by proactive government policies and rapidly advancing domestic industry capabilities. In late 2024, the National Medical Products Administration (NMPA) launched a pilot program for segmented biologics production, allowing facilities to specialize in distinct stages of manufacturing to enhance efficiency while maintaining strict GMP compliance. Leading Chinese companies, including WuXi Biologics and the state-owned China National Pharmaceutical Group Corporation (Sinopharm), play a central role in the country’s biologics output, producing vaccines, monoclonal antibodies, and complex therapeutic proteins. These initiatives reflect China’s strategic emphasis on strengthening its biologics manufacturing ecosystem, improving regulatory alignment, fostering innovation, and supporting both domestic healthcare demands and expanding global export opportunities.
GMP Biologics Market- Competitive Landscape:
The global GMP biologics market is highly competitive, driven by rising demand for advanced therapeutics and biologic treatments, and features a mix of multinational pharmaceutical companies and regional manufacturers. Market participants distribute biologics through contract manufacturing, direct collaborations with healthcare providers, and specialized biopharmaceutical channels. Competition centers on factors such as production quality, adherence to GMP standards, technological innovation, cost efficiency, and regulatory compliance. Companies strengthen their market presence through strategic initiatives, including expanding production capacity, investing in research and development, forming partnerships, and executing targeted acquisitions. Leading players such as WuXi Biologics and Samsung Biologics continue to expand their global footprint via state-of-the-art manufacturing facilities and strategic collaborations.
Recent Developments:
- In December 2025, Samsung Biologics announced the acquisition of its first U.S. drug manufacturing facility from GlaxoSmithKline for approximately $280 million, expanding biologics production capacity in the United States and reinforcing its long-term manufacturing presence.
- In April 2025, WuXi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign at a new 15,000L production line at its Hangzhou site. This milestone represents the successful scaling of one of Asia’s largest single-use bioreactor systems, enhancing the company’s commercial manufacturing capabilities and global supply potential.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Samsung Biologics
- WuXi Biologics
- Amgen Inc.
- Pfizer Inc.
- Roche Holding AG
- Novartis AG
- Merck & Co.
- Bristol Myers Squibb
- Sanofi
- Lonza Group
- Catalent Inc.
- Thermo Fisher Scientific
- Cobra Biologics
- AstraZeneca plc
- Charles River Laboratories International, Inc.
- Rentschler Biopharma SE
- Others
GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Cell & Gene Therapies
GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Immunology
- Infectious Diseases
- Rare Diseases
- Cardiovascular Diseases
GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032
- Process Development
- Analytical Testing Service
- Fill-Finish Service
- Upstream Manufacturing
- Downstream Processing
GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032
- Clinical Scale
- Commercial Scale
- Pilot Scale
GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Biopharmaceutical Companies
- Contract Development & Manufacturing Organizations (CDMOs)
- Research Institutes
- Clinical Research Organizations (CROs)
GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. GMP Biologics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. GMP Biologics Market Snippet by Product Type
2.1.2. GMP Biologics Market Snippet by Application
2.1.3. GMP Biologics Market Snippet by Service
2.1.4. GMP Biologics Market Snippet by Manufacturing Scale
2.1.5. GMP Biologics Market Snippet by End User
2.1.6. GMP Biologics Market Snippet by Country
2.1.7. GMP Biologics Market Snippet by Region
2.2. Competitive Insights
3. GMP Biologics Key Market Trends
3.1. GMP Biologics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. GMP Biologics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. GMP Biologics Market Opportunities
3.4. GMP Biologics Market Future Trends
4. GMP Biologics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. GMP Biologics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. GMP Biologics Market Landscape
6.1. GMP Biologics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. GMP Biologics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Monoclonal Antibodies (mAbs)
7.1.3. Recombinant Proteins
7.1.4. Vaccines
7.1.5. Cell & Gene Therapies
8. GMP Biologics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Oncology
8.1.3. Immunology
8.1.4. Infectious Diseases
8.1.5. Rare Diseases
8.1.6. Cardiovascular Diseases
9. GMP Biologics Market – By Service
9.1. Overview
9.1.1. Segment Share Analysis, By Service, 2024 & 2032 (%)
9.1.2. Process Development
9.1.3. Analytical Testing Services
9.1.4. Fill-Finish Services
9.1.5. Upstream Manufacturing
9.1.6. Downstream Processing
10. GMP Biologics Market – By Manufacturing Scale
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Clinical Scale
10.1.3. Commercial Scale
10.1.4. Pilot Scale
11. GMP Biologics Market – By End User
11.1. Overview
11.1.1. Biopharmaceutical Companies
11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
11.1.3. Research Institutes
11.1.4. Clinical Research Organizations (CROs)
12. GMP Biologics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. GMP Biologics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. GMP Biologics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. GMP Biologics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. GMP Biologics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. GMP Biologics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- GMP Biologics Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Samsung Biologics
13.2.2. WuXi Biologics
13.2.3. Amgen Inc.
13.2.4. Pfizer Inc.
13.2.5. Roche Holding AG
13.2.6. Novartis AG
13.2.7. Merck & Co.
13.2.8. Bristol Myers Squibb
13.2.9. Sanofi
13.2.10. Lonza Group
13.2.11. Catalent Inc.
13.2.12. Thermo Fisher Scientific
13.2.13. Cobra Biologics
13.2.14. AstraZeneca plc
13.2.15. Charles River Laboratories International, Inc.
13.2.16. Rentschler Biopharma SE
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Samsung Biologics
- WuXi Biologics
- Amgen Inc.
- Pfizer Inc.
- Roche Holding AG
- Novartis AG
- Merck & Co.
- Bristol Myers Squibb
- Sanofi
- Lonza Group
- Catalent Inc.
- Thermo Fisher Scientific
- Cobra Biologics
- AstraZeneca plc
- Charles River Laboratories International, Inc.
- Rentschler Biopharma SE
- Others
GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Cell & Gene Therapies
GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Immunology
- Infectious Diseases
- Rare Diseases
- Cardiovascular Diseases
GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032
- Process Development
- Analytical Testing Service
- Fill-Finish Service
- Upstream Manufacturing
- Downstream Processing
GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032
- Clinical Scale
- Commercial Scale
- Pilot Scale
GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Biopharmaceutical Companies
- Contract Development & Manufacturing Organizations (CDMOs)
- Research Institutes
- Clinical Research Organizations (CROs)
GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
